CArotid Robotic Procedure Evaluation

This is a prospective, single-arm, monocenter study to evaluate the R-one use in carotid artery stenting procedures. Up to 8 patients will be included and followed at 30 days.

Inclusion criteria

• Age ≥18 years;
• Candidate for CAS
• Presence of a WEB-diaphragm lesion at carotid artery ostium, proved by non-invasive imaging (CTA or MRA)
• No minimum delay between previous stroke therapy (IMT) is required
• Double antiplatelet therapy the day before the procedure and 1 month after the procedure is required
• The patient provides written informed consent as approved by the applicable Ethics Committee and is willing to comply with all study requirements including 30 days follow-up.
• The patient is affiliated with a social security scheme

Exclusion criteria

• Target lesion has atherosclerotic or dissection stenosis or occlusion;
• Treatment of in-stent restenosis, or prior stent in the target vessel proximal to the target lesion;
• CAS performed at the end of intracranial mechanical thrombectomy
• Contra-indications of double antiplatelet therapy the day before the procedure and 1 month after the procedure
• Patients under judicial protection, tutorship or curatorship
• Any patient participating in another clinical study valuating a drug or a medical device (except registries for which the primary endpoint has not been evaluated);
• Pregnant and breast-feeding women or intention to become pregnant prior to completion of all follow-up procedures.